UK Investor Magazine cover image

GlaxoSmithKline, UK house prices, and Sovereign Metals with Alan Green

UK Investor Magazine

00:00

Ador, the Company's Flagship Project, Has Grown Revenues by Ten %

Ador is developing molecular bi biology solutions to provide rapid testing for bacterial, viral or fungal infections using a dna and arinasa sampling. Networking siber division revenues fell following the sale of n g soft, but it's realized a capital gain of 13 million dollars from that. The company expects to deliver revenues and abida substantially ahead of market expectations, with growth of over forty % year on year. And i think you'll see in the coming weeks, the term the company is going to er. It will be a porting to the market.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app